Developer docs
API playgroundTry for free, no card

Search company profiles

DePuy Synthes

Full company profile

uuid0004nwo

Namestring
DePuy Synthes
Legal namestring
Medical Device Business Services, Inc.
Company typeenum
Private
Founded yearint
1895
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersRaynham, United States
HQ citystring
Raynham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic implants, joint reconstruction, surgical robotics, spine surgery devices, digital surgery platform
Industry7 codes
1Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
CodeHLAHAEAAPrimaryYes
2Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
3Surgical Robotics & Computer-Assisted Surgery Platforms
CodeHLAHADAFPrimaryNo
4Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
CodeHLAHAEABPrimaryNo
5Spine Implants & Motion Preservation (Fusion/Disc/Interspinous)
CodeHLAHAEACPrimaryNo
6Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
CodeHLAHADAAPrimaryNo
7Orthopedic & Implantable Devices (Plates, Screws, TPLO, Prosthetics)
CodeHLAMAFAEPrimaryNo
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Orthopedic Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Hip and Knee Replacement Devices
TypeHardware Sales
Description

Primary revenue stream from hip, knee and shoulder implants and surgical instruments for joint reconstruction procedures.

finance.yahoo.com
2Spine Products
TypeHardware Sales
Description

Spinal implant systems and surgical devices for spine procedures.

finance.yahoo.com
3Enabling Tech / Digital Surgery
TypeHardware Sales
Description

VELYS Digital Surgery platform including robotic systems, navigation software, and related disposables and services.

openpr.com
4Trauma and Extremity Products
TypeHardware Sales
Description

Products for foot and ankle, trauma, and extremities procedures including acquired CrossRoads Extremity Systems portfolio.

financialpost.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1VELYS
Description

Digital Surgery portfolio including robotic surgery systems and surgical navigation technology for joint replacement procedures

jnjmedtech.com
+5 more records
Core offering1 text field

DePuy Synthes manufactures and sells orthopedic medical devices and surgical equipment, including hip, knee, and shoulder implants, trauma and extremity products, spine implants, sports medicine devices, and craniomaxillofacial products. The company also offers the VELYS Digital Surgery portfolio of robotic-assisted and AI-enabled navigation systems for joint replacement procedures, sold to hospitals, surgical centers, and orthopedic surgeons worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 57% reduction in workflow time for hip replacement surgeries (from 5.33 to 2.27 minutes for landmark identification)
+1 more record
Product overview1 text field

DePuy Synthes provides one of the most comprehensive Orthopaedics portfolios in the world spanning joint reconstruction (hip, knee, shoulder), trauma, craniomaxillofacial, spinal surgery, sports medicine, and extremities, along with the VELYS Digital Surgery portfolio of robotic and enabling technologies. The portfolio includes the ATTUNE Knee System, INHANCE Shoulder System, and TIGHT-N Anchor as core implant products; VELYS Hip Navigation with AI Assistance and VELYS Active Robotic-Assisted System as enabling technology modules; MatrixSTERNUM for thoracic procedures; and acquired brands including CrossRoads Extremity Systems for foot and ankle. The VELYS platform serves as the digital surgery ecosystem integrating robotics, navigation, and AI capabilities across the reconstruction portfolio.

Product and service9 records
1VELYS Digital Surgery Platform
CategoryDigital Surgery / Enabling Technology
Description

Enabling technology portfolio of robotic surgery systems, surgical navigation software, and AI-assisted solutions for joint replacement procedures including hip, knee, and shoulder.

2ATTUNE Knee System
CategoryKnee Reconstruction Implants
Description

A comprehensive, integrated primary knee replacement system designed to improve functional outcomes for patients, performance for surgeons, and efficiency for healthcare providers.

3TIGHT-N Anchor
CategorySports Medicine / Tendon Fixation
Description

Next-generation tendon fixation device designed to protect tendons from wrap and laceration, featuring sub-cortical placement for high-strength fixation in sports medicine and ligament repair procedures.

4INHANCE Shoulder System
CategoryShoulder Reconstruction Implants
Description

Stemless shoulder replacement implant with ONE STEP PREP Glenoid designed to streamline shoulder arthroplasty procedures and address long-standing inefficiencies in shoulder surgery.

5VELYS Hip Navigation with AI Assistance
CategoryDigital Surgery / Surgical Navigation
Description

FDA 510(k)-cleared software-as-a-medical-device (SaMD) for total hip arthroplasty that automates image interpretation and landmark identification using AI trained on over 16,000 de-identified X-ray and fluoroscopic images.

6MatrixSTERNUM Fixation System
CategoryCraniomaxillofacial / Thoracic Fixation
Description

Plate and screw assembly for post-operative chest wall stabilization following open-heart and thoracic surgeries.

7VELYS Active Robotic-Assisted System
CategorySpine Surgery Robotics
Description

FDA-cleared robotic-assisted surgery system for spinal fusion procedures developed in collaboration with eCential Robotics.

8CrossRoads Extremity Systems Portfolio
CategoryFoot and Ankle Implants
Description

Portfolio of elective foot and ankle products including minimally invasive surgical solutions for bunions and hammertoes.

9DePuy Synthes Skills Lab / Johnson & Johnson Institute Training
CategoryMedical Education Services
Description

Hands-on surgeon training programs and skills labs in joint replacement and robotic-assisted surgical techniques, delivered through facilities such as the DePuy Synthes Skills Lab in Pune and the Johnson & Johnson Institute.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-06-08
Description

Partnership to launch the DePuy Synthes Skills Lab in Pune, India - a dedicated training facility for orthopaedic surgeons providing hands-on training in advanced joint replacement and robotic-assisted surgical techniques, with focus on surgeons from tier 2 and tier 3 cities.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-26
Description

DePuy Synthes announced a definitive agreement to acquire selective rights to develop, manufacture, and commercialize Gemtrack miniature Radiofrequency tracking technology developed by MinMaxMedical (Grenoble-based). The technology eliminates line-of-sight dependency of current infrared optical tracking systems and will be integrated into the VELYS Digital Surgery platform for shoulder, hip, and knee procedures.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-26
Description

Exclusive distribution agreement for NOVOSIS, an advanced growth-factor bone graft substitute, covering United States, Canada, and Australia. An IDE study for spine procedures is actively enrolling in the U.S. The agreement builds on a prior February 2025 distribution arrangement for Korea, Taiwan, Thailand, India, Hong Kong, and Macau, with rights of first negotiation for additional global markets.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-08-01
Description

Partnership with eCential Robotics to enhance surgical navigation and robotic-assisted spine surgery capabilities. In August 2024, DePuy Synthes launched the FDA-cleared VELYS Active Robotic-Assisted System for spinal fusion surgeries developed with eCential Robotics.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-02-10
Description

DePuy Synthes acquired CrossRoads Extremity Systems, a Tennessee-based foot and ankle devices manufacturer, to expand its portfolio of elective foot and ankle products including minimally invasive solutions for bunions and hammertoes. The acquisition marked the conclusion of HealthpointCapital's investment in the company.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Stryker is one of the largest global orthopaedics companies, with the Mako robotic surgery system directly competing with DePuy Synthes' VELYS platform. Stryker's portfolio spans joint reconstruction, trauma, spine, and surgical instruments, making it the closest comparable in scale and product breadth.

TypeDirect peer
Description

Zimmer Biomet is a top global orthopaedics competitor offering hip, knee, shoulder implants and the ROSA robotic surgery platform that competes head-to-head with VELYS. Both companies serve hospitals and ambulatory surgery centers with similar joint reconstruction and trauma portfolios.

TypeDirect peer
Description

Smith & Nephew competes directly in orthopaedics reconstruction (hip/knee/shoulder), trauma, extremities and sports medicine - the same specialty mix as DePuy Synthes. Both serve hospitals and surgical centers with comparable implant lines and robotics initiatives.

TypeBroad incumbent
Description

Medtronic is a dominant player in spine implants and surgical navigation/robotics (Mazor, StealthStation), overlapping with DePuy Synthes' spine and enabling-tech franchises. As a much larger diversified medtech incumbent, it competes with DePuy Synthes in select categories rather than across the full orthopaedic portfolio.

TypeDirect peer
Description

NuVasive (now part of Globus Medical) specializes in spine surgery and enabling technologies directly competing with DePuy Synthes' spine franchise. Comparable focus on minimally invasive spine procedures and surgical integration aligns it closely as a spine-focused peer.

TypeDirect peer
Description

Globus Medical is a major spine and orthopaedics company offering implants, enabling technology, and surgical robotics that overlaps with DePuy Synthes' spine and VELYS platforms. The 2023 NuVasive merger expanded Globus's scale to compete more directly across DePuy Synthes' portfolio.

TypeDirect peer
Description

Wright Medical's extremities and trauma portfolio (now integrated into Stryker post-2020 acquisition) competes directly with DePuy Synthes' trauma/extremities business and the acquired CrossRoads Extremity Systems line. Specialization in foot, ankle, and upper extremities makes it a focused peer in those sub-segments.

TypeEmerging player
Description

ConforMIS develops patient-specific knee replacement systems, intersecting with DePuy Synthes' ATTUNE Knee System in the joint reconstruction category. As a smaller player focused on personalized implants, it represents an emerging niche competitor in the knee segment.

TypeBroad incumbent
Description

B. Braun's Aesculap division offers orthopaedic implants, surgical instruments, and spinal products that overlap with DePuy Synthes' portfolio. As part of the broader B. Braun medtech conglomerate, it competes across multiple orthopaedic segments without specializing in DePuy Synthes' specific niches.

TypeDirect peer
Description

Orthofix specializes in spine, orthobiologics, and bone-growth stimulation products competing with DePuy Synthes' spine franchise and bone-graft offerings (e.g., NOVOSIS). Its narrower portfolio makes it a focused direct peer in spinal and trauma-adjacent categories.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A8 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DePuy Synthes

Orthopedic Medical Devicesdepuysynthes.com

DePuy Synthes firmographics

Firmographics
Name
DePuy Synthes
Legal name
Medical Device Business Services, Inc.
Website
https://depuysynthes.com
Company type
Private
Founded year
1895
Operating status
Operating
Headcount range
5,001–10,000 employees
Ownership category
akta.pro rank

DePuy Synthes industry classification

Industry
Product category
Orthopedic Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
akta.pro secondary industries
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF), Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Orthopedic & Implantable Devices (Plates, Screws, TPLO, Prosthetics) (HLAMAFAE)

Keywords

  • Orthopedic implants
  • Joint reconstruction
  • Surgical robotics
  • Spine surgery devices
  • Digital surgery platform

Where DePuy Synthes is headquartered

Location

Headquarters

HQ city
Raynham
HQ country
United States
HQ region
North America

Offices3 records

Markets served

DePuy Synthes business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations

Revenue model

  1. Hip and Knee Replacement Devices: Primary revenue stream from hip, knee and shoulder implants and surgical instruments for joint reconstruction procedures.
  2. Spine Products: Spinal implant systems and surgical devices for spine procedures.
  3. Enabling Tech / Digital Surgery: VELYS Digital Surgery platform including robotic systems, navigation software, and related disposables and services.
  4. Trauma and Extremity Products: Products for foot and ankle, trauma, and extremities procedures including acquired CrossRoads Extremity Systems portfolio.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

DePuy Synthes product offering

Product offering

Core offering

DePuy Synthes manufactures and sells orthopedic medical devices and surgical equipment, including hip, knee, and shoulder implants, trauma and extremity products, spine implants, sports medicine devices, and craniomaxillofacial products. The company also offers the VELYS Digital Surgery portfolio of robotic-assisted and AI-enabled navigation systems for joint replacement procedures, sold to hospitals, surgical centers, and orthopedic surgeons worldwide.

Product overview

DePuy Synthes provides one of the most comprehensive Orthopaedics portfolios in the world spanning joint reconstruction (hip, knee, shoulder), trauma, craniomaxillofacial, spinal surgery, sports medicine, and extremities, along with the VELYS Digital Surgery portfolio of robotic and enabling technologies. The portfolio includes the ATTUNE Knee System, INHANCE Shoulder System, and TIGHT-N Anchor as core implant products; VELYS Hip Navigation with AI Assistance and VELYS Active Robotic-Assisted System as enabling technology modules; MatrixSTERNUM for thoracic procedures; and acquired brands including CrossRoads Extremity Systems for foot and ankle. The VELYS platform serves as the digital surgery ecosystem integrating robotics, navigation, and AI capabilities across the reconstruction portfolio.

Differentiator

Problem solved

Functional benefit

Brands

  • VELYS: Digital Surgery portfolio including robotic surgery systems and surgical navigation technology for joint replacement procedures
  • ATTUNE
  • INHANCE
  • TIGHT-N Anchor
  • MatrixSTERNUM
  • Gemtrack

Products and services

  • VELYS Digital Surgery Platform Enabling technology portfolio of robotic surgery systems, surgical navigation software, and AI-assisted solutions for joint replacement procedures including hip, knee, and shoulder.
  • ATTUNE Knee System A comprehensive, integrated primary knee replacement system designed to improve functional outcomes for patients, performance for surgeons, and efficiency for healthcare providers.
  • TIGHT-N Anchor Next-generation tendon fixation device designed to protect tendons from wrap and laceration, featuring sub-cortical placement for high-strength fixation in sports medicine and ligament repair procedures.
  • INHANCE Shoulder System Stemless shoulder replacement implant with ONE STEP PREP Glenoid designed to streamline shoulder arthroplasty procedures and address long-standing inefficiencies in shoulder surgery.
  • VELYS Hip Navigation with AI Assistance FDA 510(k)-cleared software-as-a-medical-device (SaMD) for total hip arthroplasty that automates image interpretation and landmark identification using AI trained on over 16,000 de-identified X-ray and fluoroscopic images.
  • MatrixSTERNUM Fixation System Plate and screw assembly for post-operative chest wall stabilization following open-heart and thoracic surgeries.
  • VELYS Active Robotic-Assisted System FDA-cleared robotic-assisted surgery system for spinal fusion procedures developed in collaboration with eCential Robotics.
  • CrossRoads Extremity Systems Portfolio Portfolio of elective foot and ankle products including minimally invasive surgical solutions for bunions and hammertoes.
  • DePuy Synthes Skills Lab / Johnson & Johnson Institute Training Hands-on surgeon training programs and skills labs in joint replacement and robotic-assisted surgical techniques, delivered through facilities such as the DePuy Synthes Skills Lab in Pune and the Johnson & Johnson Institute.

Quantifiable outcome

  • 57% reduction in workflow time for hip replacement surgeries (from 5.33 to 2.27 minutes for landmark identification)
  • +1 more outcomes

Companies that use DePuy Synthes

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles2 records

DePuy Synthes technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature5 records

DePuy Synthes partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor and core.

  • Saishree Vitalife HospitalsminorStrategic or Co-development Partner · 8 June 2026Partnership to launch the DePuy Synthes Skills Lab in Pune, India - a dedicated training facility for orthopaedic surgeons providing hands-on training in advanced joint replacement and robotic-assisted surgical techniques, with focus on surgeons from tier 2 and tier 3 cities.
  • MinMaxMedicalcoreTechnology or Integration · 26 May 2026DePuy Synthes announced a definitive agreement to acquire selective rights to develop, manufacture, and commercialize Gemtrack miniature Radiofrequency tracking technology developed by MinMaxMedical (Grenoble-based). The technology eliminates line-of-sight dependency of current infrared optical tracking systems and will be integrated into the VELYS Digital Surgery platform for shoulder, hip, and knee procedures.
  • CGBIOcoreChannel Partner/ Reseller/ Distributor · 26 May 2026Exclusive distribution agreement for NOVOSIS, an advanced growth-factor bone graft substitute, covering United States, Canada, and Australia. An IDE study for spine procedures is actively enrolling in the U.S. The agreement builds on a prior February 2025 distribution arrangement for Korea, Taiwan, Thailand, India, Hong Kong, and Macau, with rights of first negotiation for additional global markets.
  • eCential RoboticscoreTechnology or Integration · 1 August 2024Partnership with eCential Robotics to enhance surgical navigation and robotic-assisted spine surgery capabilities. In August 2024, DePuy Synthes launched the FDA-cleared VELYS Active Robotic-Assisted System for spinal fusion surgeries developed with eCential Robotics.
  • CrossRoads Extremity SystemscoreStrategic or Co-development Partner · 10 February 2022DePuy Synthes acquired CrossRoads Extremity Systems, a Tennessee-based foot and ankle devices manufacturer, to expand its portfolio of elective foot and ankle products including minimally invasive solutions for bunions and hammertoes. The acquisition marked the conclusion of HealthpointCapital's investment in the company.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

DePuy Synthes competitors and assessment

Company assessment

Direct peers

  • Stryker Corporation: Stryker is one of the largest global orthopaedics companies, with the Mako robotic surgery system directly competing with DePuy Synthes' VELYS platform. Stryker's portfolio spans joint reconstruction, trauma, spine, and surgical instruments, making it the closest comparable in scale and product breadth.
  • Zimmer Biomet: Zimmer Biomet is a top global orthopaedics competitor offering hip, knee, shoulder implants and the ROSA robotic surgery platform that competes head-to-head with VELYS. Both companies serve hospitals and ambulatory surgery centers with similar joint reconstruction and trauma portfolios.
  • Smith & Nephew: Smith & Nephew competes directly in orthopaedics reconstruction (hip/knee/shoulder), trauma, extremities and sports medicine - the same specialty mix as DePuy Synthes. Both serve hospitals and surgical centers with comparable implant lines and robotics initiatives.
  • NuVasive: NuVasive (now part of Globus Medical) specializes in spine surgery and enabling technologies directly competing with DePuy Synthes' spine franchise. Comparable focus on minimally invasive spine procedures and surgical integration aligns it closely as a spine-focused peer.
  • Globus Medical: Globus Medical is a major spine and orthopaedics company offering implants, enabling technology, and surgical robotics that overlaps with DePuy Synthes' spine and VELYS platforms. The 2023 NuVasive merger expanded Globus's scale to compete more directly across DePuy Synthes' portfolio.
  • Wright Medical (Stryker Trauma & Extremities): Wright Medical's extremities and trauma portfolio (now integrated into Stryker post-2020 acquisition) competes directly with DePuy Synthes' trauma/extremities business and the acquired CrossRoads Extremity Systems line. Specialization in foot, ankle, and upper extremities makes it a focused peer in those sub-segments.
  • Orthofix Medical: Orthofix specializes in spine, orthobiologics, and bone-growth stimulation products competing with DePuy Synthes' spine franchise and bone-graft offerings (e.g., NOVOSIS). Its narrower portfolio makes it a focused direct peer in spinal and trauma-adjacent categories.

Broad incumbents

  • Medtronic: Medtronic is a dominant player in spine implants and surgical navigation/robotics (Mazor, StealthStation), overlapping with DePuy Synthes' spine and enabling-tech franchises. As a much larger diversified medtech incumbent, it competes with DePuy Synthes in select categories rather than across the full orthopaedic portfolio.
  • B. Braun (Aesculap): B. Braun's Aesculap division offers orthopaedic implants, surgical instruments, and spinal products that overlap with DePuy Synthes' portfolio. As part of the broader B. Braun medtech conglomerate, it competes across multiple orthopaedic segments without specializing in DePuy Synthes' specific niches.

Emerging players

  • ConforMIS: ConforMIS develops patient-specific knee replacement systems, intersecting with DePuy Synthes' ATTUNE Knee System in the joint reconstruction category. As a smaller player focused on personalized implants, it represents an emerging niche competitor in the knee segment.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

DePuy Synthes social profiles

Digital presence

DePuy Synthes financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DePuy Synthes leadership team

Management profile

Number of profiles

Profiles4 records

DePuy Synthes subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

DePuy Synthes funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DePuy Synthes M&A and investment

M&A and investment

M&A8 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DePuy Synthes

What does DePuy Synthes do?

DePuy Synthes manufactures and sells orthopedic medical devices and surgical equipment, including hip, knee, and shoulder implants, trauma and extremity products, spine implants, sports medicine devices, and craniomaxillofacial products. The company also offers the VELYS Digital Surgery portfolio of robotic-assisted and AI-enabled navigation systems for joint replacement procedures, sold to hospitals, surgical centers, and orthopedic surgeons worldwide.

Is DePuy Synthes a public or private company?

DePuy Synthes is a private company. It is classified as corporate owned and is currently operating.

When was DePuy Synthes founded?

DePuy Synthes was founded in 1895. It employs 5,001 to 10,000 people.

Where is DePuy Synthes based?

DePuy Synthes is headquartered in Raynham, United States, in the North America region.

How does DePuy Synthes make money?

Four revenue lines are on record. Hip and Knee Replacement Devices are the primary driver. The others are spine Products, enabling Tech / Digital Surgery and trauma and Extremity Products.

Who are DePuy Synthes's main competitors?

Direct peers on record are Stryker Corporation, Zimmer Biomet, Smith & Nephew, NuVasive, Globus Medical, Wright Medical (Stryker Trauma & Extremities) and Orthofix Medical. Broad incumbents are Medtronic and B. Braun (Aesculap). ConforMIS is listed as an emerging player.

Does DePuy Synthes have an API?

No public API is recorded for DePuy Synthes.

What industry is DePuy Synthes in?

DePuy Synthes's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketScreenerSMAIO Signs Distribution Agreement with DePuy Synthes in the United StatesSMAIO signed a distribution agreement with DePuy Synthes to accelerate its U.S. market development. The deal focuses on KEOPS-4ME, combining data analysis, 3D surgical planning, and custom rods, aiming to expand hospital access and support commercial growth. SMAIO will publish its half-year results and third-quarter revenue on October 13.36krJohnson & Johnson Unveils 3 Consecutive New Innovations: Ushering Fracture Treatment into the Fully Automatic Mode EraDePuy Synthes unveiled three trauma products at the OTA Annual Meeting: the MAXFRAME AUTOSTRUT automatic external fixation system, the VOLT plate system with four new models, and the VELYS Trauma AI intraoperative guidance system. The automatic fixation system performs up to 20 daily adjustments with 94% accuracy, and VELYS is scheduled for US launch in 2027. The products aim to shift the business model from one-time consumables to subscription-based workflow.News-MedicalDePuy Synthes showcases next-generation trauma innovations at OTA 2026DePuy Synthes will showcase four new VOLT plating systems, MAXFRAME AUTOSTRUT with Bluetooth, and VELY AI-assisted surgery at OTA 2026 in Nashville. The company cites 178 million new fractures annually and plans to launch VELY in 2027 in the U.S.GurufocusDePuy Synthes Showcases Next-Generation Trauma Innovations at OTDePuy Synthes will showcase four new VOLT plating systems, MAXFRAME AUTOSTRUT with Bluetooth, and VELYS AI-assisted surgery at the 2026 OTA Annual Meeting in Nashville. The company cites 178 million new fractures globally each year as the driver for its innovation. VELYS will launch in the U.S. in 2027.Stock TitanDePuy Synthes to Showcase 4 Plating Systems in 2026DePuy Synthes will showcase four new VOLT plating systems, MAXFRAME AUTOSTRUT with Bluetooth, and VELYS AI-assisted surgery at OTA 2026 in Nashville. The company also expands its trauma commercial portfolio with soft tissue and biologics offerings. VELYS is set to launch in the U.S. in 2027.Business Wire BlogDePuy Synthes Showcases Next-Generation Trauma Innovations at OTA 2026DePuy Synthes will showcase four new VOLT plating systems, MAXFRAME AUTOSTRUT with Bluetooth, and VELYS Trauma AI-assisted surgery at OTA 2026. The company cites 178 million new fractures globally annually and plans to launch VELYS in 2027.Medical Device NetworkApollo rumoured to be eyeing $20bn takeover of J&J’s orthopaedics businessApollo Global Management is reportedly in non-binding talks to acquire J&J's orthopaedics unit, DePuy Synthes, for nearly $20bn. The deal would be Apollo's largest healthcare acquisition, but talks could end or another bidder may enter. J&J is considering a spinout to sharpen its focus.QuartzJ&J in talks to sell DePuy Synthes to Apollo for $20 billionJohnson & Johnson is in talks to sell its DePuy Synthes orthopedics unit to Apollo Global Management for nearly $20 billion. The unit generated $9.3 billion in sales last year, and J&J could spin it off publicly. A mid-2027 separation timeline remains intact.FierceBiotechJ&J looking to offload orthopedics unit in $20B deal to Apollo: BloombergJohnson & Johnson is nearing a $20 billion deal to sell its DePuy Synthes orthopedics unit to Apollo Equity Management, with talks expected to conclude within weeks. The unit generated $9.3 billion in sales in 2025, and J&J could also spin it off via IPO.WsjJ&J Is In Talks to Sell Its Hips-and-Knees Business to Apollo for $20 BillionApollo Global Management is in talks to acquire Johnson & Johnson's DePuy Synthes orthopedics business for around $20 billion. The deal may not close, as another suitor could emerge or the transaction could fail.